Skip to main content

Table 5 Mean values and frequency of altered lipid profile

From: Apolipoprotein E and plasminogen activator inhibitor 1 gene polymorphism in children with chronic renal insufficiency associated with cardiovascular disease

Group Parameter Mean ST.D Min Max P value Significant Frequency (%)
GR1 Triglycerides (T.G) 200.5 112.03 59.0 366.0 0.034 Sig 46
GR2 177.75 84.46 66.0 428.0
GR3 107.40 51.12 45.0 203.0
GR1 Total cholesterol (CHO) 177.6 41.07 135.5 273.0 0.569 N.S 28
GR2 167.0 36.96 112.0 267.0
GR3 183.6 57.21 114.0 282.0
GR1 High-density lipoprotein (HDL) 42.40 8.03 29.00 52.0 0.247 N.S 20
GR2 46.35 5.48 31.00 56.0
GR3 48.00 16.56 34.00 85.0
GR1 Low-density lipoprotein (LDL) 96.80 3.05 71.0 198.0 0.496 N.S 44
GR2 87.15 42.65 28.0 179.0
GR3 114.10 42.90 69.0 204.0
GR1 CHO/HDL 4.54 1.87 2.9 8.3 0.625 N.S 16
GR2 3.61 0.95 2.3 6.4
GR3 4.00 1.40 2.7 7.6